(Q35009772)

5 August 2017

1 reference

title

Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease (English)

1 reference

5 August 2017

0 references

0 references

Amy H Moore

1

1 reference

5 August 2017

M K O'Banion

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Advanced Drug Delivery Reviews

5 August 2017

published in

1 reference

5 August 2017

volume

54

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1627-1656

1 reference

Cell activation and inflammatory response following traumatic axonal injury in the rat

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Pathobiology of ischaemic stroke: an integrated view

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Potential mechanisms of interleukin-1 involvement in cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cell mediators of inflammation in the Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Immune and inflammatory responses in the CNS: modulation by astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Glial cytokines in Alzheimer's disease: review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Reactive microgliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglia as mediators of inflammatory and degenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

beta-Amyloid converts an acute phase injury response to chronic injury responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Role of microglia in senile plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglial activation in early stages of amyloid beta protein deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid beta protein (A beta) removal by neuroglial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alzheimer's disease in Down's syndrome: clinicopathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

GFAP mRNA increases with age in rat and human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Altered antigen expression of microglia in the aged rodent CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Trauma-induced proliferation of astrocytes in the brains of young and aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuritic pathology and dementia in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Tau mutations cause frontotemporal dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The origins of Alzheimer disease: a is for amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Caspase activity sows the seeds of neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Dying neural cells activate glia through the release of a protease product.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cerebral microvascular pathology in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Clearance of amyloid beta-peptide from brain: transport or metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

TGF-beta 1 is an organizer of responses to neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Transforming growth factor-betas in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostaglandins as putative neurotoxins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Elevated CSF prostaglandin E2 levels in patients with probable AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Elevated CSF prostaglandin E2 levels in patients with probable AD

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Microglial contribution to oxidative stress in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Activation of NADPH oxidase in Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Nitric oxide in neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Evidence for cyclooxygenase activation by nitric oxide in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The role of complement in Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Complement component C1q modulates the phagocytosis of Abeta by microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Alpha2 macroglobulin and the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The interleukin-1 genotype as a severity factor in adult periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Functional Analysis of a New Polymorphism in the Human TNF alpha Gene Promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Function and regulation of prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenases and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Indomethacin reverses the microglial response to amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Role of cyclooxygenase 2 in acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase inhibition as a strategy to ameliorate brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Peroxisome proliferator-activated receptors: from genes to physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Regulation and inhibition of phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The growing phospholipase A2 superfamily of signal transduction enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Phospholipases A2 in ischemic and toxic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Expression of prostaglandin E synthase mRNA is induced in beta-amyloid treated rat astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

New trends in thromboxane and prostacyclin modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen replacement therapy and memory in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

High-dose estradiol improves cognition for women with AD: results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cognitive function in nondemented older women who took estrogen after menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estradiol protects against ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen as a neuroprotectant in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Oxidative alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Neuropsychological detection and characterization of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A prospective study of cognitive function and onset of dementia in cognitively healthy elders.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Propentofylline attenuates microglial reaction in the rat spinal cord induced by middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Differential regulation of microglial activation by propentofylline via cAMP signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

The search for disease-modifying treatment for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Interleukin-1beta promotes repair of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900162-X

7 January 2021

10.1016/S0169-409X(02)00162-X

Identifiers

DOI

1 reference

5 August 2017

1 reference